Hughes Steven George Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$410,347.24

Insider Activity of Hughes Steven George

According to the SEC Form 4 filings, Hughes Steven George, being in a position of

  1. Chief Medical Officer at Atrium Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 7268 shares for $526,045,
    over all time since 2025-01-21, has bought 0 shares, and sold 79943 shares for $3.48M.

Biography of Hughes Steven George

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $526,0452100

Comparison of Insiders on Amount of Buys and Sells

2026-01-21SaleAvidity Biosciences, Inc.
RNA
Chief Medical Officer
4,895
0.0032%
$72.45$354,643
2026-01-07SaleAvidity Biosciences, Inc.
RNA
Chief Medical Officer
2,373
0.0018%
$72.23$171,402
2025-09-22SaleAvidity Biosciences, Inc.
RNA
Chief Medical Officer
2,208
0.0016%
$40.58$89,601
2025-09-15SaleAvidity Biosciences, Inc.
RNA
Chief Medical Officer
1,542
0.0014%
$45.41$70,022
2025-08-22SaleAvidity Biosciences, Inc.
RNA
Chief Medical Officer
2,208
0.0017%
$46.40$102,462
2025-08-13SaleAvidity Biosciences, Inc.
RNA
Chief Medical Officer
1,542
0.0012%
$46.66$71,950
2025-08-06SaleAvidity Biosciences, Inc.
RNA
Chief Medical Officer
51,650
0.0479%
$42.74$2.21M
2025-03-20SaleAvidity Biosciences, Inc.
RNA
Chief Medical Officer
9,578
0.008%
$31.06$297,491
2025-01-21SaleAvidity Biosciences, Inc.
RNA
Chief Medical Officer
3,947
0.0031%
$28.59$112,856
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.